Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (161-170 of 567) with videos related to

Pageof 57
Sort By:
Annals of Internal Medicine|December 15, 1989
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and managementD C Sane, R M Califf, E J Topol, et al.
The New England Journal of Medicine|February 13, 1997
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter?E D Peterson, L K Shaw, E R DeLong, et al.
The American Journal of Cardiology|April 1, 1997
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigatorsM J Eisenberg, R M Califf, E A Cohen, et al.
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
The American Journal of Cardiology|October 1, 1991
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status IndexC L Nelson, J E Herndon, D B Mark, et al.
Journal of Electrocardiology|January 1, 1993
ST-segment recovery as an endpoint in acute myocardial infarction trials. Past, present, and futureR F Veldkamp, J E Pope, S T Sawchak, et al.
Journal of Cardiac Failure|June 23, 2001
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomesM R Shah, V Hasselblad, S S Stinnett, et al.
JAMA|January 5, 2002
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trialR J Dolor, D L Witsell, A S Hellkamp, et al.
The American Journal of Cardiology|November 13, 2001
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathyM R Shah, V Hasselblad, M Gheorghiade, et al.
Journal of the American College of Cardiology|August 1, 1997
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesB S Crenshaw, S R Ward, C B Granger, et al.
Pageof 57

Showing results (161-170 of 567) with videos related to

Sort By:
Pageof 57
Annals of Internal Medicine|December 15, 1989
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and managementD C Sane, R M Califf, E J Topol, et al.
The New England Journal of Medicine|February 13, 1997
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter?E D Peterson, L K Shaw, E R DeLong, et al.
The American Journal of Cardiology|April 1, 1997
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigatorsM J Eisenberg, R M Califf, E A Cohen, et al.
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
The American Journal of Cardiology|October 1, 1991
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status IndexC L Nelson, J E Herndon, D B Mark, et al.
Journal of Electrocardiology|January 1, 1993
ST-segment recovery as an endpoint in acute myocardial infarction trials. Past, present, and futureR F Veldkamp, J E Pope, S T Sawchak, et al.
Journal of Cardiac Failure|June 23, 2001
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomesM R Shah, V Hasselblad, S S Stinnett, et al.
JAMA|January 5, 2002
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trialR J Dolor, D L Witsell, A S Hellkamp, et al.
The American Journal of Cardiology|November 13, 2001
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathyM R Shah, V Hasselblad, M Gheorghiade, et al.
Journal of the American College of Cardiology|August 1, 1997
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesB S Crenshaw, S R Ward, C B Granger, et al.
Pageof 57